Biomedical Research Ethics Board
Submission Checklist

Researchers are required to submit one electronic copy of the full application to the ethics.office@usask.ca. If someone other than the PI is submitting, the PI must be cc’d on the email submission. For submissions requiring full board review, please cc: caitlin.prebble@usask.ca

Protocol # (if applicable):	Principal Investigator:
Study Title:

Risk Assessment:
Above minimal risk full board review:	Minimal risk delegated review:

	Included	N/A	
Participant Information and Consent Form(s)	☐	☐	
Participant recruitment tools (advertisements, posters, notices, website)	☐	☐	
Full study protocol	☐	☐	
Clinical Investigator Brochure and/or Product Monograph	☐	☐	
Questionnaire(s)/study instrument(s)/patient diary(s)	☐	☐	
Health Canada No Objection Letter*	☐	☐	
Copy of the contract* (unless study facilitated by CTSU)	☐	☐	
Verification of registration on clinicaltrials.gov (protocol registration system)*	☐	☐	
Documentation of REB approval from another institution where research will also be conducted, if available	☐	☐	
One copy of letter(s) of support from schools/community groups or collaborating	☐	☐	
agencies/institutions (where applicable)			
Students accessing existing health data (i.e. chart audit) are required to complete the McMaster Chart Review tutorial 	☐	☐	
All student researchers are required to complete the TCPS 2: CORE Tutorial 	☐	☐	
			
The University of Saskatchewan assesses a review fee of $4,000.00 for industry-sponsored research. The submission should include acknowledgement that the review fee applies and include the address where the invoice should be sent.
*Note that these particular items may not be complete or available at the time of submission. The Certificate of Approval will not be issued until the No Objection Letter and Clinical Trials registration number have been received, and the contract has been signed.

Submission completed by:	Phone Number:

February 2021